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Abstract
Background: Recruitment of adolescents to intervention studies is a known challenge. For randomized controlled
trials (RCT) to be generalizable, reach must be assessed, which means ascertaining how many of the intended
population actually participated in the trial. The aim of this study was to evaluate the reach and representativeness
of an RCT evaluating the effectiveness of a complex intervention for adolescents with chronic conditions.
Methods: A mixed methods sequential explanatory design was employed. Firstly, quantitative cross-sectional data
from the RCT, patient registries and medical records were collected and analysed regarding baseline differences
between participants and non-participants in the trial. Secondly, qualitative data on their reasons for participating or
not were collected and analysed with content analysis to explain the quantitative findings.
Results: Participants showed larger differences in effect sizes and a significantly more complex chronic condition
than non-participants. No other statistically significant differences were reported, and effect sizes were negligible.
Reasons for declining or accepting participation were categorized into three main categories: altruistic reasons,
personal reasons and external reasons and factors.
Conclusions: Integration of quantitative and qualitative findings showed that participation in the RCT was affected
by disease complexity, the perceived need to give back to healthcare and research and the adolescents’ willingness
to engage in their illness. To empower adolescents with chronic conditions and motivate them to participate in
research, future intervention studies should consider developing tailored recruitment strategies and
communications with sub-groups that are harder to reach.
Keywords: Adolescent, Chronic disease, Mixed method, Process evaluation, Randomized controlled trial, Transition
of care
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Background
Recruitment of adolescents and young persons with
chronic conditions to research studies is a known
challenge [1]. For intervention studies, such as random-
ized controlled trials (RCT), recruitment rates in this
population have ranged from 10 to 50% [2–6]. Factors
considered to affect adolescents’ participation in RCTs
studies may be clinical (e.g. disease severity) [7],
demographic (e.g. household income and geographic
location), and individual (e.g. personal incentives, trust
in healthcare providers and school performance) [8–12].
Moreover, an additional barrier to recruitment is that
participation in research studies means the adolescent
has to engage in their illness [13]. For many adolescents
this is challenging, as young persons want to live their
lives as a healthy normal teen, and not spend excessive
time thinking about their illness [14].
In most settings, adolescents living with a chronic con-
dition have to transfer their care from a pediatric to an
adult setting at age 18. During this transitional phase,
these individuals are subject to several risks, such as care
gaps in medical follow-up [15], increased healthcare
utilization [16, 17], and difficulties in achieving educa-
tional and vocational milestones [18]. To prepare adoles-
cents for the transfer to adult care and transition to
adulthood, transition programs are advocated [19–21].
RCTs have been conducted to evaluate the effectiveness
of transition programs, with positive effects in disease-
related knowledge, self-efficacy, self-management [22] and
reduced delay in transfer to adult care [23]. However,
RCTs evaluating these programs have lacked reporting of
components to assess external validity such as representa-
tiveness of their samples and response rates [22, 24], so
generalizability of current transition programs is limited.
In order to understand how representative an RCT is
of its underlying population, and how well findings can
be translated into practice, the ‘reach’ is important to
consider [25]. Determining the reach of an RCT provides
knowledge of the absolute number, proportion and
representativeness of individuals who were willing to
participate in the trial [26]. When evaluating representa-
tiveness of such trials, effectiveness data is rarely enough
to understand if the RCT was successful in achieving the
outcome. Indeed, RCTs are viewed as the gold standard
when evaluating new healthcare innovations such as
transition programs [22, 27, 28]. However, RCTs are vul-
nerable to selection bias. In trials for patients with
chronic conditions, as many as 70% of studies including
patients with chronic conditions have been found to
have samples unrepresentative of the target population
[29], with participants often healthier than patients seen
in clinical practice [29, 30]. The lack of knowledge on
reach and representativeness of participants in transition
programs [22, 24] poses several challenges. Firstly, if
samples of RCTs do not represent patients in real life
settings, clinicians cannot assess which findings that can
be translated into clinical practice [31]. Secondly, RCTs
are usually the basis for health economic evaluations
and decisions on resource allocation in healthcare [32,
33]. If samples of these trials are biased, decision-makers
risk making faulty assessments as to which interventions
that are cost-effective and could be implemented into
practice. Thirdly, we lack knowledge about which
adolescents and sub-groups that are more difficult to
recruit for RCTs. The aim of this study was therefore to
evaluate the reach and representativeness of an RCT
evaluating the effectiveness of a healthcare intervention
for adolescents with chronic conditions in transition to
adulthood. Two specific objectives were formulated to
achieve this aim: (i) to compare clinical and
demographic characteristics of participants and non-
participants in the RCT, and (ii) to describe adolescents’
reasons for participating or not participating in the RCT
from their own perspective.
Methods
Design
A mixed methods sequential explanatory design was uti-
lized, consisting of two phases [34]. Phase one consisted
of quantitative cross-sectional data from the STEP
STONES (Swedish Transition Effects Projects Support-
ing Teenagers with chrONic mEdical conditionS) pro-
ject, where a transition program for adolescents with
congenital heart disease (CHD) was evaluated through
an RCT [35]. Phase two consisted of qualitative data on
participants’ and non-participants’ reasons for accepting
or declining participation. A mixed methods approach
to answering the research question was used to facilitate
a deeper understanding of what factors affect reach in
complex interventions from a quantitative and qualita-
tive perspective. The Good Reporting of A Mixed
Methods Study (GRAMMS) checklist [36] was followed
for this article (additional file 1). The present study is
part of a larger process evaluation study of the STEP
STONES project in which the implementation, mecha-
nisms of impact and contextual factors are explored
within the RCT [37]. A study protocol describing the full
extent of the process evaluation has been previously
published [38].
Setting
In Sweden, care for individuals living with CHD is
mainly organized around seven university hospitals
(CHD-centres). However, follow-up is also provided at
regional hospitals connected to the university hospitals.
These seven centres provide specialized care for both
pediatric and adult patients with CHD, with the transfer
to adult care occurring at age 18. Medical follow up is
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based on current treatment guidelines with the follow-
up frequency being determined by the complexity of the
CHD, varying between visits on a yearly basis to every
3–5 years [39].
The intervention study
The STEPSTONES project was performed at the
seven CHD centres in Sweden, with the hypothesis
that adolescents (age 16–18.5 years) participating in
the transition program in addition to usual care will
have a higher patient empowerment score than ado-
lescents receiving only usual care (primary outcome)
[40]. The transition program is a complex interven-
tion comprising multiple components delivered by a
transition coordinator who works at the outpatient
pediatric cardiology clinic. In short, the transition
program entails three outpatient visits with 1-year in-
tervals and one information day for adolescents and
their parents [35]. The effects of the transition pro-
gram are evaluated using a hybrid RCT where a lon-
gitudinal observational study is embedded within a
conventional RCT (see Fig. 1). The two largest cen-
tres are designated as RCT centres, where participants
are individually randomized to either the intervention
group or the comparison group. The remaining five
centres are control groups in which no contamination
from the intervention is possible. The total sample
size of the trial is 210 patients with 70 patients in
each arm, based on power calculation of the primary
outcome [35]. For the present study, only the RCT
centres were included in the analysis.
Sample
The inclusion criteria for the present study were the
same as those of the RCT: 1) age 16 at recruitment, 2)
literate, 3) Swedish-speaking, and 4) having a CHD as
defined by Mitchell et al. [41] with follow-up planned
in an Adult Congenital Heart Disease (ACHD) clinic.
Exclusion criteria were: 1) previous heart transplant-
ation, and 2) illiterate or non-Swedish speaking. The
cohort for the quantitative study (phase 1) was catego-
rized into two groups: participants (n = 134) and non-
participants (n = 223). Participants were patients who
had consented to participate in the study and had been
randomized to either intervention or control group.
Non-participants were patients who either actively
declined participation, were unreachable, or did not
return the informed consent to participate in the study
despite several reminders. For the qualitative study
(phase 2), we used nested sampling whereby a sub-sam-
ple of patients from the group of participants (n = 10)
and non-participants (n = 20) were sampled for
participation [34] (see Fig. 2).
Fig. 1 Flow chart of STEPSTONES RCT. TC = Transition Coordinator
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Data collection
Quantitative data was retrieved from the national regis-
ter SWEDCON (SWEDish register of CONgential heart
disease) (http://www.ucr.uu.se/swedcon.se) [42] and
medical records. Patients’ medical records were screened
for residential address and Google Maps™ was used to
calculate the geographical distance between the patients’
home and the hospital where the transition program (i.e.
intervention) was delivered.
Qualitative data were collected from two sources. All
patients declining participation in the STEPSTONES
project at the time of recruitment to the RCT were
asked their reasons for doing so by the data collection
officer. If the patient provided a reason, this was docu-
mented in the RCT enrolment forms. For patients
accepting participation in the RCT, data were collected
from patients participating in the intervention group
after participation in the RCT through semi-structured
interviews. In total, 10 interviews were carried out with
adolescents aged 18–19 by the main author (MS). In the
sampling of participants, we employed purposive sam-
pling to select a diverse group with maximum variation
[43] in terms of disease complexity, sex and intervention
centre. The interviews were carried out face-to-face (n =
1), over the telephone (n = 5) or email (n = 4) as we
wanted the adolescents to choose the communication
medium that they were most comfortable with [44, 45].
The interviews comprised three questions: “Can you tell
me why you agreed to participate in the study?”, “What
do you think are the benefits of participating in this kind
of study?” and “What do you think are reasons for not
wanting to participate in this kind of study?”, followed
by probing questions (additional file 2). Due to constric-
tions in the ethical approval received for this study, non-
participants could not be approached for probing
questions. Therefore, in the interviews performed with
the participants, we added the third question on reasons
for not wanting to participate in this kind of study in
order to illuminate and give more depth to potential rea-
sons on not wanting to participate from the adolescents’
point-of-view. The interviews performed face-to-face or




Statistical analyses were performed in SPSS (Statistical
Package for Social Sciences) v.24. As the continuous var-
iables were not normally distributed, they were repre-
sented as medians and interquartile ranges. Categorical
variables were expressed as absolute numbers and pro-
portions. Variables concerning clinical, demographic and
health service use were compared between participants
and non-participants using significance testing (signifi-
cance level < 0.05). The chi-square test and Fishers’ exact
test was used for categorical variables and the Mann-
Whitney U test for continuous variables. In order to
calculate the magnitude of difference between partici-
pants and non-participants, we calculated effect sizes.
For categorical variables, we used Cohens’ w. For
continuous variables, we used the Wilcoxon’s test by cal-
culating r = Z/ √n. Z represents the Wilcoxon test statis-
tic, which is the Mann-Whitney U Z statistic. Cut-offs
for Cohens w and r were graded as follows: 0.1–0.3 =
small difference, 0.3–0.5 =moderate difference, and >
0.5 = large difference [46].
Qualitative data
Inductive content analysis of the manifest content of
reasons for participation and non-participation was
Fig. 2 Flow chart of quantitative and qualitative phases in the study
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performed according to Graneheim and Lundman [47].
This analysis method is suitable for analysing texts and
was therefore appropriate due to our using data from
various sources. The analysis was performed with the
computer-assisted qualitative analysis software, NVivo
version 12. We chose to analyse and present the data
from the participants and non-participants as a whole.
This was because the texts from the RCT recruitment
protocols (non-participants’ reasons) where short sum-
maries, and the interviews (participants) provided more
depth and explanations that were not present in the
summaries from the recruitment protocols. The text
from the recruitment protocols and transcribed inter-
views were read through several times to get a grasp of
the whole. Meaning units were then identified as con-
stellations of words and sentences that answered the aim
of the study and contained a common meaning. These
meaning units were then condensed, which in some
cases meant a reducing the number of words but keep-
ing the core essence of the meaning unit. In this process,
codes were created and compared to each other, with
those that were similar in content sorted into the same
group. These groups formed the basis for subcategories.
This procedure was repeated for the subcategories,
resulting in the main categories [47]. Two of the authors
(MS & ELB) with experience in qualitative methods and
content analysis were responsible for carrying out the
analysis and continuously discussed the findings with
the other co-authors.
Ethical considerations
The study was approved by the Regional Ethical Review
Board in Gothenburg, Sweden (No.931–15) and the board
of directors of SWEDCON. The study was performed in
accordance with the Declaration of Helsinki [48]. For the
quantitative study, data was retrieved from a national
register, so informed consent could not be retrieved from
each individual participant for this particular study.
However, each patient enrolled in the register is informed
that their data could be used for research purposes. In
addition, the patient is informed about their right to refuse
permission to use their data. For the qualitative study, in-
formed consent was retrieved from participants after they
had been given oral and written information about the
study. Non-participants who provided a reason for
declining were informed that their answers would be used
for research purposes and consented to this. All data were
stored coded and password-protected. During the
interview period, the interviews performed over email
were copied to a password-protected database and stored
in a designated folder in the main authors email program.
When the analysis was completed, the emails were deleted
from the email program to protect the participants’
confidentiality.
Results
Phase 1 – quantitative study
From the total eligible population identified in SWED
CON (n = 357), 37.5% (n = 134) participated in the STEP
STONES RCT. Statistically significant differences were
observed between participants and non-participants for
primary diagnosis and disease complexity (Table 1). A
larger proportion of participants had a more complex
CHD than non-participants. The statistically significant
results also presented large effect sizes for primary
diagnosis w = 1.46 and disease complexity w = 0.54.
There were not statistical differences between partici-
pants and non-participants for sex, geographic distance
to hospital, proportion receiving cardiac pharmacother-
apy, proportion receiving special aid in school, and the
number of cardiac interventions and surgeries, and the
effect sizes were negligible.
Phase 2 – qualitative study
Table 1 presents the demographic characteristics of the
participants in the qualitative study (n = 30). The analysis
resulted in three main categories, with adjacent subcat-
egories (Table 2).
Altruistic reasons
In this category, reasons that facilitated participation
were addressed. This category was based on three
subcategories: helping other adolescents in the same
situation, contributing to research and improved care,
and participating was the right thing to do.
Helping other adolescents in the same situation
This subcategory included the wish to help other adoles-
cents in the same situation, even if their participation
did not help themselves. Believed reasons were that they
could be supportive by showing other adolescents in the
same situation that they were not alone and that other
adolescents were going through the same process of
transitioning into adulthood.
“Yes, for example, I think mentally they know they
are not alone; there are other people who have
similar problems and who behave similarly in life.
And maybe ... many have different ways of acting ...
but I think it helps people to show that they are not
alone…”
– 19-year-old (ID: 2030).
Contributing to research and improved care
Here, the participants described a wish to contribute to
research by sharing their experiences, but also through
their participation in the study.
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“Why I did was because I felt kind of like I might as
well help, I think it’s good that you carry out studies
and research like this and then I thought in that
case, I might as well because I’m experiencing this –
I can share my experiences. And how I felt about this
whole process and all that.”
– 19-year-old (ID: 2047).
Participating was the right thing to do
For some participants, this subcategory was shaped on
the assumption that participation in a research study
was a good deed and that deciding to contribute came
naturally.
Personal reasons
This category highlighted personal reasons for partici-
pating or not participating in the study. Four subcat-
egories were identified that were considered factors
affecting the decision to participate.
Meeting others in the same situation
Being given the opportunity to meet other adolescents
in the same situation could lead to participants and
others in the same situation feeling less alone. An-
other aspect was the need to show others that there
are young people with CHD who are doing well and
living normal lives.
Table 1 Demographic and clinical characteristics of participants and non-participants
Quantitative study Qualitative study
Participants
n = 134 (%)
Non-participants
n = 223 (%)
Statistical test p-value Effect size* Participants
n = 10 (%)
Non-participants
n = 20 (%)
Female sex 61 (45.5) 99 (44.4) X2 = 0.43 p = 0.836 w = 0.02 5 (50) 10 (50)





U = 14,002 z = −0.65
p = 0.516 r = − 0.03 – –
Proportion with cardiac pharmacotherapy 18 (13.4) 34 (16) X2 = 0.344 p = 0.557 w = 0.02 – –
Proportion with special
aid in school
5 (4) 13 (5.8) X2 = 1.032 p = 0.31 w = 0.06 – –
Disease complexity** X2 = 10.195 p = 0.017 w = 0.54
Mild 14 (10.4) 52 (23.3) 3 (30) 3 (15)
Moderate 84 (62.7) 119 (53.4) 6 (60) 12 (60)
Severe 35 (26.2) 48 (21.5) 1 (10) 5 (25)
Primary diagnosis Fishers’ exact test = 27.634 p = 0.023 w = 1.46 – –
Single ventricle physiology 5 (3.7) 10 (4.5)
Tricuspid valve abnormalities 1 (0.7) 4 (1.8)
Tetralogy of Fallot 15 (11.1) 16 (7.2)
Double outlet right ventricle 0 (0.0) 10 (4.5)
Truncus arteriosus 1 (0.7) 2 (0.9)
Transposition of the
great arteries
20 (14.9) 15 (6.7)
Coarctation of the aorta 25 (18.7) 26 (11.7)
Atrioventricular septal defect 4 (3.0) 5 (2.2)
Ebstein anomaly 1 (0.7) 2 (0.9)
Pulmonary valve abnormalities 15 (11.2) 22 (9.9)
Aortic valve abnormalities 26 (19.4) 37 (16.6)
Atrial septal defect 5 (3.7) 16 (7.2)
Ventricular septal defect 9 (6.7) 30 (13.5)
Mitral valve abnormalities 3 (2.2) 13 (5.8)
Pulmonary vein abnormalities 3 (2.2) 9 (4.0)
Patent ductus arteriosus 1 (0.7) 4 (1.8)
Other 0 (0.0) 1 (0.4)
Number of cardiac operations 1.0
(IQR = 2)
1.0 (IQR = 2) Mann-Whitney
U = 13,899.500 z = −1.148
p = 0.251 r = −0.06 – –
Number of catheterizations 0.00
(IQR = 0)
0.00 (IQR = 0) Mann-Whitney
U= 14,402 z = − 1.08
p = 0.28 r = −0.05 – –
*Cut-offs for Cohen’s w and Cohen’s r = 0.1–0.3 small; 0.3–0.5 =moderate; > 0.5 = large
**Complexity of CHD categorized according to 2018 AHA/ACC Guideline for Management of Adults with Congenital Heart Disease
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“Yes exactly! Seeing that you are not alone is
something that very often satisfies the brain.”
– 19-year-old (ID: 2030).
“…that there are people who are also doing well with
this heart disease…”
– 19-year-old (ID: 2030).
However, meeting other young adolescents with CHD
could be a reason for not wanting to participate, as some
adolescents felt it was awkward to talk about their
condition in front of others.
Educational objectives
Wanting to learn more about CHD and how the condi-
tion would affect the adolescents in their daily lives were
reasons that facilitated participation. The adolescents
considered participating in the study an advantage to
participate in the study because they saw it as an oppor-
tunity to learn more about their illness, the transfer to
adult care and the transition to adulthood with a chronic
condition.
“It’s also clear that there were benefits from this
study for me as well; it gave back to me a bit
because the study meant a lot that I would learn
about my illness - then I understood”
– 19-year-old (ID: 1051).
“Well... maybe I wanted more understanding of what
it was because I didn't even know ... I’d just heard
that I had something with my heart and I kind of
went to the doctor sometimes. I didn’t know what it
was at all. But then maybe I want more information
about it.”
– 19-year-old (ID: 2038).
Feeling healthy and therefore not needing the study
This subcategory described why adolescents did not
participate in the study due to not feeling ill or
affected by their CHD. For this reason, they also
believed they would be a bad fit for the study.
Moreover, there as a perception among the adoles-
cents that young people participating in studies like
this were affected more severely by CHD than they
were.
“And I also think that there are probably a lot of
people who aren’t really affected by their CHD, just
like me, and then maybe they feel that there’s even
less reason for them to participate. Like that you
don’t fit in there in any way, that you have nothing
to do with the study because you are not character-
ized by your heart failure.”
– 19-year-old (ID: 1051).
Fearing what the study would evoke and demand of them
This subcategory comprised both emotional and
practical reasons for adolescents choosing not to partici-
pate. Most commonly, adolescents expressed a percep-
tion that youths with CHD were afraid to think and talk
about their health, and were fed up with having a
chronic illness.
“Like…if you’ve gone through a lot of surgeries
and examinations….that it’s a big part of their
life. It’s not that much fun you know. We met a
guy who’d gone through at least 8 operations in
his life. So it might be sensitive to talk about
that. You never know what’s gonna happen and
if you survive….I don’t know, it might be difficult.
It’s not something that you go round bragging
about”
– 18-year-old (ID: 2080).
Practical reasons were also given for not participating,
such as not having enough time to contribute to the
study, that the hospital was too far away from the
patient’s home, and that the additional hospital visits
that randomization to the intervention group would
entail would be emotionally and practically stressful for
the adolescents.
Table 2 Categories and subcategories from the qualitative content analysis
Altruistic reasons Personal reasons External reasons and factors
Reasons for participating To help other adolescents in the same
situation
To contribute to research and improved
care
Participating was the right thing to do





Meeting others in the same situation
Being healthy and therefore not needing the study
Fearing what the study would evoke and demand
of me
Parents as barriers
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External reasons and factors
The final category included reasons and factors that
were external to the adolescents’ own perceptions and
decisions to participate in the research study. Here,
parental influence on the decision to participate was
illustrated in two subcategories.
Parents as facilitators
Parents could be active partners in the decision to
participate in the study.
“It was kind of a collective decision by both my
parents; if you are 16, you are usually a little indeci-
sive, very hard to think that you shouldn’t do it. But
we talked it over briefly and thought like, why not?
So nothing wrong with that. So you could say it was
a bit of a joint decision, but it was a decision that I
would also like to make myself, you could say.”
– 19-year-old (ID: 2030).
Parents as barriers
In this subcategory, there were reasons as to why parents
could potentially be barriers to participation. Domestic
issues, such as conflicts within the family, were also
brought up as a barrier to participation.
“Maybe that parents are more involved and tell the
kids that they should not join, that it is unnecessary
or so”
– 19-year-old (ID: 2047).
Discussion
Having integrated findings from the quantitative and quali-
tative phases of this study, we can conclude that partici-
pants differed from non-participants in regard to disease
complexity. A potential reason for this may be that adoles-
cents with a more complex conditions felt grateful towards
research and the healthcare system, and were thus moti-
vated to give back. In contrast, non-participants (who as a
group generally had a less complex condition) mentioned
not wanting to engage in their illness more than necessary
and not recognizing the illness as a part of their social iden-
tity as reasons for declining participation. These findings
are in line with results from previous studies in this patient
population [49]. It is also in keeping with observations in
other patient populations, for instance, in RCTs concerning
young persons with asthma, where non-participants have
been shown to be healthier and less likely to require medi-
cation [2]. Differences in quality of life and health status
could also be a reason why patients with more severe
conditions want to participate in a transition intervention.
Several studies have shown that patients with moderate and
severe complexity of CHD have a lower health related
quality of life than patients with milder CHD [50–52].
Moreover, adolescents with complex CHD experience
lower self-reported health and physical functioning [53, 54].
Both health status and quality of life might be incentives
that affect participation in an RCT evaluating an interven-
tion aiming to improve the adolescents’ ability to manage
their health and care in adulthood.
An important aspect to consider regarding representa-
tiveness of the sample of this study is that patients with
complex CHD generally have a higher frequency of out-
patient visits [39]. As patients in the STEPSTONES RCT
had a more complex CHD than those who declined
participation, this will have an impact on upcoming
economic evaluations, as patients seen in the RCT are the
primary data source for cost-effectiveness ratios. It is
therefore important for upcoming studies evaluating simi-
lar interventions to consider performing budget impact
analyses adjacent to cost effectiveness studies in order to
estimate the true healthcare budget impact of complex
healthcare interventions [55]. In the present study, we did
not include a variable on health service use as SWEDCON
was established in 2009 and data for this variable has not
been added retrospectively for all centres. As young per-
sons with CHD consume more health care resources dur-
ing the early years of life [56], including this variable
would have introduced bias into our results.
Although our findings suggest that disease complexity
may be one factor affecting participation in an RCT
evaluating a complex healthcare intervention for adoles-
cents, our results should be interpreted bearing in mind
some methodological caveats. Firstly, we did not have
access to individual level data on socioeconomic status
for the complete sample. This has been an important
factor in previous studies comparing participants to
non-participants, where poor socioeconomic status has
been a barrier to participation [7–10]. Indeed, domestic
issues were also raised in our qualitative findings as a
potential reason for declining participation. Secondly, we
did not have any measure of self-reported health. The
health status measure registered in SWEDCON, PedsQL
4.0 [57], has been recently implemented into standard
practice in pediatric cardiology and coverage in the
register is therefore limited. Thirdly, as multiple compar-
isons between groups increases the risk for type I errors
we also used the effect size estimates. The effect size is
independent of sample size and significance level, and
measure the extent of an association between variables
which is a more accurate basis for treatment decisions
[58, 59]. Finally, we only received reasons for declining
participation from 8% of all non-participants, which
makes it difficult to generalize the findings. Furthermore,
as ethical constrictions prevented us from interviewing
these non-participants, we had to rely on the short
statements they had provided on the RCT enrolment
forms.
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In the light of these limitations, this study has several
strengths. To our knowledge, this is the first published
study assessing the reach of an RCT evaluating a transi-
tion program for adolescents with chronic condition. As
evidence on transition programs is scarce [60], this is an
important step in providing evidence on effectiveness. The
recruitment for the RCT was based on a register which
has high concordance with the medical records, therefore
increasing validity [61]. Moreover, by reporting data on
the reach and representativeness of this RCT before the
outcomes of the effectiveness evaluation, we can avoid
making biased interpretation of outcomes [37]. Finally, the
use of mixed methods, where qualitative methods were
used to explain quantitative findings, gave a deeper under-
standing of factors that impact on the decision to partici-
pate or not in intervention studies for young persons
living with chronic conditions. One insight especially
gained from mixing methods was that adolescents with a
milder condition might benefit from tailored messages
while being recruited to intervention studies. From our
findings, these patients are more likely to decline partici-
pation due to, for example, not wanting to engage in their
illness and fear of standing out for the wrong reasons. In
future trials with this patient population, researchers and
clinicians should carefully consider to this issue. Indeed, it
would be useful to involve young persons in the develop-
ment phase of the intervention, and then not only focus
on developing the clinical intervention but also focus on
effective recruitment strategies with tailored messages that
can empower adolescents with milder conditions to par-
ticipate in research trials [62, 63].
Conclusion
Factors positively affecting adolescents’ participation in
RCTs evaluating healthcare interventions are higher dis-
ease complexity and a will to give back to research and
healthcare, along with an interest to learn more about
their health and care. Factors that negatively affect par-
ticipation negatively are milder disease complexity, along
with the feeling of being healthy and not wanting to en-
gage in the illness. Future studies within this area should
investigate the impact of socio-demographic variables on
study participation, along with self-reported health. The
creation of tailored recruitment messages with relevant
stakeholders to reach hard-to-recruit sub-groups is an
area which needs increased attention and a topic for fu-
ture research initiatives.
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